Subversion of host defense mechanisms by adenoviruses

Current Topics in Microbiology and Immunology

Volumn 269, Issue , 2002, Pages 273-318

  Burgert, H G ^a   Ruzsics, Z ^a   Obermeier, S ^a   Hilgendorf, A ^a   Windheim, M ^a   Elsing, A ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN KINASE; PROTEIN P53; TUMOR NECROSIS FACTOR; E1A PROTEIN; VIRUS PROTEIN;

ADENOVIRUS; APOPTOSIS; ARTICLE; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; GENE EXPRESSION; HOST RESISTANCE; HUMAN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS CLASSIFICATION; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION; AMINO ACID SEQUENCE; ANIMAL; COMPARATIVE STUDY; DOWN REGULATION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW; SEQUENCE ALIGNMENT; VIROLOGY;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADENOVIRUS E1A PROTEINS; ADENOVIRUS E3 PROTEINS; AMINO ACID SEQUENCE; ANIMAL; APOPTOSIS; COMPARATIVE STUDY; DOWN-REGULATION; HUMAN; IMMUNITY, NATURAL; INTERFERONS; KILLER CELLS, NATURAL; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, CYTOTOXIC; VIRUS REPLICATION; ANIMALS; HUMANS;

ADENOVIRIDAE;

EID: 0035988045     PISSN: 0070217X     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-59421-2_16     Document Type: Article

References (213)

1. Adenovirus early region 1A modulation of interferon antiviral activity
2. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance
3. Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death
4. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein
5. Regulation of p53 stability
6. Death receptors: Signaling and modulation
7. Sequence of the immunoregulatory early region-3 and flanking sequences of adenovirus type-35
8. The tumor necrosis factor ligand and receptor families
9. Characterization of an 11K protein produced by early region 3 of mouse adenovirus type 1
10. Three adenovirus E3 proteins cooperate to evade apoptosis by TRAIL receptor-1 and 2
11. Cutting edge: Adenovirus E19 has two mechanisms for affecting class I MHC expression
12. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
13. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR
14. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α
15. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
16. Human adenoviruses: Evading detection by cytotoxic T lymphocytes
17. Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-κB
18. Studies of adenovirus subtypes and down-regulation of HLA class I expression: Correlations to natural-killer-mediated cytolysis
19. Bcl-2 and adenovirus E1B 19kDa protein prevent E1A-induced processing of CPP32 and cleavage of poly (ADP-ribose) polymerase
20. Adenovirus E1B 19kDa and Bcl-2 proteins interact with a common set of cellular proteins
21. Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver
22. Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression
23. Subversion of the MHC class I antigen presentation pathway by adenoviruses and herpes simplex viruses
24. Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses
25. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens
26. The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition
27. "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens
28. Epidermal growth factor receptor is down-regulated by a 10.400 MW protein encoded by the E3 region of adenovirus
29. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway
30. Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF
31. Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis
32. The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells
33. Control of apoptosis by human adenovirus genes
34. p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis
35. The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2
36. Reovirus-induced apoptosis is mediated by TRAIL
37. High adenoviral loads stimulate NFκB-dependent gene expression in human vascular smooth muscle cells
38. A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells
39. E1 A oncogene expression in target cells induces cytolytic susceptibility at a post-recognition stage in the interaction with killer lymphocytes
40. E1A oncogene-induced cellular sensitization to immune-mediated apoptosis is independent of p53 and resistant to blockade by E1B 19kDa protein
41. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis
42. Coatomer interaction with di-lysine endoplasmic reticulum retention motifs
43. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum
44. Use of the E2F transcription factor by DNA tumor virus regulatory proteins
45. The DNA sequence of adenovirus type 40
46. To die or not to die - The quest of the TRAIL receptors
47. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively
48. Early region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgenera B and C
49. Tumor necrosis factor alpha induces the adenovirus early 3 promoter by activation of NF-κB
50. Tumor necrosis factor α increases expression of adenovirus E3 proteins
51. Mitochondria as the central control point of apoptosis
52. Dichotomy between naive and memory CD4(+) T cell responses to Fas engagement
53. Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes
54. Regulatable expression of the interferon-induced double-stranded RNA dependent protein kinase PKR induces apoptosis and Fas receptor expression
55. Sequence analysis of putative E3 and fiber genomic regions of two strains of canine adenovirus type 1
56. Adenovirus E1 A renders infected cells sensitive to cytolysis by tumor necrosis factor
57. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
58. Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes
59. The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization
60. Characterization of transgenic mice containing adenovirus early region 3 genomic DNA
61. Novel proteins associated with MHC class I antigens in cells expressing the adenovirus protein E3/19K
62. Identification of amino acids within the MHC molecule important for the interaction with the adenovirus protein E3/19K
63. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA
64. Identification of class I MHC regions which bind to the adenovirus E3-19k protein
65. Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon
66. The Seattle virus watch. VII Observations of adenovirus infections
67. The endoplasmic reticulum retention signal of the E3/19K protein of adenovirus type 2 consists of three separate amino acid segments at the carboxy terminus
68. Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2
69. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-α receptors
70. Role of early region 3 (E3) in pathogenesis of adenovirus disease
71. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia
72. Interferons: Cell signalling, immune modulation, antiviral response and virus countermeasures
73. The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells
74. A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor
75. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor
76. The role of the nuclear pore complex in adenovirus DNA entry
77. The adenovirus oncoprotein Ela stimulates binding of transcription factor ETF to transcriptionally activate the p53 gene
78. CD8+ T cell effector mechanisms in resistance to infection
79. The E1b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody
80. NF-κB and the innate immune response
81. Immune evasion by cytomegalovirus - Survival strategies of a highly adapted opportunist
82. Nucleotide sequence of the EcoRI D fragment of adenovirus 2 genome
83. Nucleotide sequence of the EcoRI E fragment of adenovirus 2 genome
84. Sequence and functional analysis of the human adenovirus type 7 E3-gp19K protein from 17 clinical isolates
85. Adenovirus E3 protein causes constitutively internalized epidermal growth factor receptors to accumulate in a prelysosomal compartment, resulting in enhanced degradation
86. Characterization of the early region 3 and fiber genes of Ad7
87. Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis
88. A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes
89. Group C adenovirus DNA sequences in human lymphoid cells
90. Adenovirus immunoregulatory genes and their cellular targets
91. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death
92. Post-transcriptional control of adenovirus gene expression
93. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins
94. Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum
95. Retrieval of transmembrane proteins to the endoplasmic reticulum
96. Regulation of APO-2 ligand/trail expression in NK cells-involvement in NK cell-mediated cytotoxicity
97. Transcriptional modulation by the adenovirus E1 A gene
98. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3
99. Novel role for E4 region genes in protection of adenovirus vectors from lysis by cytotoxic T lymphocytes
100. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells
101. Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins
102. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity
103. The death domain kinase RIP mediates the TNF-induced NF-κB signal
104. The changing etiology of epidemic keratoconjunctivitis: Antigenic and restriction enzyme analyses of adenovirus types 19 and 37 isolated over a 10-year period
105. Adaptors for clathrin-mediated traffic
106. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5
107. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced elF-2 alpha kinase
108. Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line
109. Tumor necrosis factor alpha stimulates expression of adenovirus early region 3 proteins: Implications for viral persistence
110. Immune regulation: A critical link between NK cells and CTLs
111. The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid
112. The adenovirus E3-14.5K protein which is required for prevention of TNF cytolysis and for down-regulation of the EGF receptor contains phosphoserine
113. The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2
114. E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk
115. The constitutive expression of the immunomodulatory gp19k protein in E1(-), E3(-) adenoviral vectors strongly reduces the host cytotoxic T-cell response against the vector
116. Effects of adenovirus E1 A protein on interferon-signaling
117. Restoration of interferon responses of adenovirus E1A-expressing HT1080 cell lines by overexpression of p48 protein
118. Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis
119. Interaction of an adenovirus 14.7-kilodalton protein inhibitor of tumor necrosis factor alpha cytolysis with a new member of the GTPase superfamily of signal transducers
120. Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor α-inducible cellular protein containing leucine zipper domains
121. Inhibition of NF-κB activation in combination with bcl-2 expression allows for persistence of first-generation adenovirus vectors in the mouse liver
122. Proteolytic processing of peptides in the lumen of the endoplasmic reticulum for antigen presentation by major histocompatibility class I
123. Direct suppression of Stat1 function during adenoviral infection
124. Structure, function, and evolution of adenovirus-associated RNA: A phylogenetic approach
125. Immune evasion by adenoviruses
126. The early region 4 orf4 protein of human adenovirus type 5 induces p53-independent cell death by apoptosis
127. Protein sorting by tyrosine-based signals: Adapting to the Ys and wherefores
128. Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription
129. Latent adenoviral infection in the pathogenesis of chronic airways obstruction
130. The nucleotide sequence of adenovirus type 11 early 3 region: Comparison of genome type Ad11p and Ad11a
131. Surface receptors delivering opposite signals regulate the function of human NK cells
132. Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1
133. Apoptosis by death factor
134. Cell receptors involved in adenovirus entry
135. Role of alpha(v) integrins in adenovirus cell entry and gene delivery
136. Detection of adenovirus nucleic acid sequences in human tonsils in the absence of infectious virus
137. p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum
138. E1A-induced processing of procaspase-8 can occur independently of FADD and is inhibited by Bcl-2
139. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites
140. Viruses and apoptosis
141. Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens
142. Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein
143. Mechanisms of MHC class I-restricted antigen processing
144. E1B 19K inhibits Fas-mediated apoptosis through FADD-dependent sequestration of FLICE
145. TNF-α signals apoptosis through a bid-dependent conformational change in Bax that is inhibited by E1B 19K
146. Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor
147. The E1B 19K protein associates with lamins in vivo and its proper localization is required for inhibition of apoptosis
148. An inverse relation of the oncogenic potential of adenovirus-transformed cells and their sensitivity to killing by syngeneic natural killer cells
149. Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by E1A gene products
150. The major substrates for TAP in vivo are derived from newly synthesized proteins
151. The coxsackievirus-adenovirus receptor protein can function as a Cellular attachment protein for adenovirus serotypes from subgenera A, C, D, E, and F
152. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae
153. Adenovirus E1A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand
154. E1A gene expression induces susceptibility to killing by NK cells following immortalization but not adenovirus infection of human cells
155. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture
156. Update on adenovirus and its vectors
157. Targeting of membrane proteins to endosomes and lysosomes
158. The dual effect of adenovirus type 5 E1A 13 S protein on NF-kappaB activation is antagonized by E1B 19K
159. Downregulation of MHC class I expression due to interference with p105-NF kappa B1 processing by Ad12E1 A
160. Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo
161. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
162. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression
163. Conserved cysteine residues within the E3/19K protein of adenovirus type 2 are essential for binding to major histocompatibility complex antigens
164. d
165. E1A sensitizes cells to tumor necrosis factor-induced apoptosis through inhibition of IκB kinases and nuclear factor κB activities
166. Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis
167. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis
168. Region E3 of human adenoviruses; differences between the oncogenic adenovirus-3 and the non-oncogenic adenovirus-2
169. Selective export of MHC class I molecules from the ER after their dissociation from TAP
170. Nucleotide sequence of human adenovirus type 12 DNA: Comparative functional analysis
171. FADD/MORTI and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
172. How cells respond to interferons
173. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses
174. The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane
175. Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the golgi apparatus
176. Regulation of apoptosis by viral gene products
177. Adenovirus E1 A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms
178. Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function
179. The activity of cytosolic phospholipase A2 is required for the lysis of adenovirus-infected cells by tumor necrosis factor
180. Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells
181. The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell-lysis and release of adenovirus from infected-cells
182. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor
183. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
184. Viral subversion of the immune system
185. Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo
186. The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model
187. Regulation of the 26 S proteasome by adenovirus E1A
188. Genes regulating MHC class I processing of antigen
189. Two tumour necrosis factor receptors: Structure and function
190. Measles virus induces functional TRAIL production by human dendritic cells
191. Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes
192. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems
193. Cell death induction by TNF: A matter of self control
194. Tumor necrosis factor receptor and Fas signaling mechanisms
195. Regulation of apoptosis by adenovirus E1A and E1B oncogenes
196. Regulation of adenovirus gene expression in human W138 cells by an E1B-encoded tumor antigen
197. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment
198. E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53
199. PKR; a sentinel kinase for cellular stress
200. Lymphoid specific gene expression of the adenovirus early region 3 promoter is mediated by NF-κ B binding motifs
201. The E3-6.7K protein of adenovirus is an Asn-linked integral membrane glycoprotein localized in the endoplasmic reticulum
202. Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis
203. E3 transcription unit of adenovirus
204. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-κB activation
205. Genetic organization, size, and complete sequence of early region-3 genes of human adenovirus type-41
206. Mechanisms of viral interference with MHC class I antigen processing and presentation
207. Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells
208. Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling